Self-Nanoemulsifying Drug Delivery System of Glimepiride: Design, Development, and Optimization

References

1. 1.↵
   1. RoIkamp R.,
   2. Wernicke-Panten K.,
   3. Draeger E.

   Clinical profile of the novel sulphonylurea glimepiride. Diabetes Res. Clin. Pract. 1996, July (31 Suppl.), 33–42.

   OpenUrlGoogle Scholar
2. 2.↵
   1. Iwata M.,
   2. Fukami T.,
   3. Kawashima D.,
   4. Sakai M.,
   5. Furuishi T.,
   6. Suzuki T.,
   7. Tomono K.,
   8. Ueda H.

   Effectiveness of mechanochemical treatment with cyclodextrins on increasing solubility of glimepiride. Pharmazie 2009, 64 (6), 390–394.

   OpenUrlPubMedGoogle Scholar
3. 3.↵
   1. Ramon G.,
   2. Raptis S. A.,
   3. Ravella R.

   Appropriate timing of glimepiride administration in patients with type 2 diabetes millitus: a study in Mediterranean countries. Endocrine 2000, 13 (1), 117–121.

   OpenUrlPubMedGoogle Scholar
4. 4.↵
   1. Hardman J. G.,
   2. Limbird L.E.

   Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas, 10th ed.; Hardman J. G., Limbird L.E., Eds.; McGraw Hill: New York, 2001.

   Google Scholar
5. 5.↵
   1. Seedher N.,
   2. Kanojia M.

   Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. AAPS PharmSciTech 2008, 9 (2), 431–436.

   OpenUrlPubMedGoogle Scholar
6. 6.↵
   1. Seedher N.,
   2. Kanojia M.

   Co-solvent solubilization of some poorly-soluble antidiabetic drugs. Pharm. Dev. Technol. 2009, 14 (2), 185–192.

   OpenUrlPubMedGoogle Scholar
7. 7.↵
   1. Ning X.,
   2. Sun J.,
   3. Han X.,
   4. Wu Y.,
   5. Yan Z.,
   6. Han J.,
   7. He Z.

   Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques. Drug Dev. Ind. Pharm. 2011, 37 (6), 727–736.

   OpenUrlPubMedGoogle Scholar
8. 8.↵
   1. Ammar H. O.,
   2. Salama H. A.,
   3. Ghorab M.,
   4. Mahmoud A. A.

   Implication of inclusion complexation of glimepiride in cyclodextrin–polymer systems on its dissolution, stability and therapeutic efficacy. Int. J. Pharm. 2006, 320 (1-2) 53–57.

   OpenUrlPubMedGoogle Scholar
9. 9.↵
   1. Taha E. I.,
   2. Al-Suwayeh S. A.,
   3. Anwer M. K.

   Preparation, in vitro and in vivo evaluation of solid-state self-nanoemulsifying drug delivery system (SNEDDS) of vitamin A acetate. J. Drug Target. 2009, 17 (6), 468–673.

   OpenUrlPubMedGoogle Scholar
10. 10.↵
    1. Anton N.,
    2. Vandamme T. F.

    Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm. Res. 2010, 28 (5), 978–985.

    OpenUrlPubMedGoogle Scholar
11. 11.↵
    1. Grbic S.,
    2. Parojcic J.,
    3. Malenovic A.,
    4. Djuric Z.,
    5. Maksimovic M.

    A contribution to the glimepiride dissociation constant determination. J. Chem. Eng. Data 2010, 55 (3), 1368–1371.

    OpenUrlGoogle Scholar
12. 12.↵
    1. Date A. A.,
    2. Nagarsenker M. S.

    Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 2007, 329 (1-2), 166–172.

    OpenUrlPubMedGoogle Scholar
13. 13.↵
    1. Brüsewitz C.,
    2. Schendler A.,
    3. Funke A.,
    4. Wagner T.,
    5. Lipp R.

    Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int. J. Pharm. 2007, 329 (1-2), 173–181.

    OpenUrlPubMedGoogle Scholar
14. 14.↵
    1. Dabhi M. R.,
    2. Limbani M. D.,
    3. Sheth N. R.

    Preparation and in vivo evaluation of self-nanoemulsifying drug delivery system (SNEDDS) containing ezetimibe. Curr. Nanosci. 2011, 7 (4), 616–627.

    OpenUrlGoogle Scholar
15. 15.↵
    U.S. Food and Drug Administration (USFDA). USFDA Guidelines (Cited January 13, 2009). Available from http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm.

    Google Scholar
16. 16.↵
    1. Li W.,
    2. Yi S.,
    3. Wang Z.,
    4. Chen S.,
    5. Xin S.,
    6. Xie J.,
    7. Zhao C.

    Self-nanoemulsifying drug delivery system of persimmon leaf extract: optimization and bioavailability studies. Int. J. Pharm. 2011, 420 (1), 161–171.

    OpenUrlPubMedGoogle Scholar
17. 17.↵
    1. Zhu S.,
    2. Hong M.,
    3. Liu C.,
    4. Pei Y.

    Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation. Pharm. Dev. Technol. 2009, 14 (6) 642–649.

    OpenUrlPubMedGoogle Scholar
18. 18.↵
    1. Ivanova R.,
    2. Lindman B.,
    3. Alexandridis P.

    Effect of glycols on the selfassembly of amphiphilic block copolymers in water. 1. Phase diagrams and structure identification. Langmuir 2000, 16 (8), 3660–3675.

    OpenUrlGoogle Scholar
19. 19.↵
    1. Taha E. I.,
    2. Al-Saidan S.,
    3. Samy A. M.,
    4. Khan M. A.

    Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int. J. Pharm. 2004, 285 (102), 109–119.

    OpenUrlPubMedGoogle Scholar